IOC

A glimmer of hope for a neglected disease - How Chagas disease associative movement is driving progress towards disease control and elimination

Stronger control-surveillance systems for vector-borne Chagas disease

Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America

Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review

Comment on “The translational challenge in Chagas disease drug development” by Kratz et al.

Air in the tires: towards an achievable, efficacious and timely diagnosis for Chagas disease

Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection

How is global change affecting Chagas disease landscapes?

Chagas disease (American trypanosomiasis) in the context of the 2030 agenda. Insights into global warming and vector control

Reflections how IEC can empower and integrate stakeholders to denormalise Chagas disease and drive care and prevention policy: healthcare system governance at the heart of Chagas disease neglect

Reflections, suggestions for putting into practice the principles of information, education and communication - IEC on Chagas disease in a community context

Pathophysiology and new targets for therapeutic options in Chagas heart disease

The challenge of risk assessment in the riddle of Chagas heart disease

Traditional use of benznidazole with weekly clinical follow-up indicate to be an important approach for the etiologic treatment of Chagas disease

Chagas disease challenge - New techniques for diagnosis and treatment address to control in endemic areas

Chagas disease and its historicity

A note on the the discovery of Chagas' disease

Reflections on Chagas disease in the Amazon

Challenges for fighting Chagas disease in the 21st century

Chagas disease treatment: a 120-year-old challenge to public health

Waiting for a success story in prevention, control and treatment of Chagas disease in non-endemic countries

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges

A safe, effective, and reliable vaccine against Chagas disease should be described!

Brazilian immunology in Caxambu: beyond vaccination, a tribute to the pioneers of basic research in Chagas disease

The challenges for targeting Chagas disease for elimination as a public health problem

Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19

Tracing the relationship among HIV-1 sub-subtype F1 strains: a phylodynamic perspective

Intravenous whole blood transfusion results in faster recovery of vascular integrity and increased survival in experimental cerebral malaria

Morel paper is a passionate plea for the concept of “translation” with translational research (TR) as a flag

Progressive neuropathy in patients with lepromatous leprosy after multidrug therapy

Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon

Clinically silent Plasmodium vivax infections in native Amazonians of northwestern Brazil: acquired immunity or low parasite virulence?

Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients

Raising the suspicion of a non-autochthonous infection: identification of Leishmania guyanensis from Costa Rica exhibits a Leishmaniavirus related to Brazilian north-east and French Guiana viral genotypes

COVID-19 outbreaks among crew members in non-cruise vessels anchoring in Salvador, Brazil, 2021

Increased angiogenesis parallels cardiac tissue remodelling in experimental acute Trypanosoma cruzi infection

Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil

Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil

Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide

Immunoanalysis of different antigenic preparations of Angiostrongylus cantonensis for neuroangiostrongyliasis diagnosis improvement

Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing

An updated gene regulatory network reconstruction of multidrug-resistant Pseudomonas aeruginosa CCBH4851

Heterogeneous persistence of Mycobacterium leprae in oral and nasal mucosa of multibacillary patients during multidrug therapy

Lack of serological and molecular evidences of Zika virus circulation in non-human primates in three states from Brazil

New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole

Analysis of a novel class A β-lactamase OKP-B-6 of Klebsiella quasipneumoniae: structural characterisation and interaction with commercially available drugs

In vitro activity of Schinus terebinthifolius extract and fractions against Sporothrix brasiliensis

Leishmania enriettii visceralises in the trachea, lungs, and spleen of Cavia porcellus

Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil

Inscrever-se em IOC